CCL2 and inflammatory bowel disease: Previous studies have demonstrated that pro-inflammatory mediators expressed by macrophages, such as NO, MCP-1, iNOS, and COX-2, contribute to the exacerbation of IBD, resulting in mucosal inflammation [43,44,45,46].